Skip to content

Depression: all studies

Page 301 of 1,034: studies 3,001 to 3,010 of 10,336, newest first. Back to the depression overview

Research

How Mindfulness Training May Help to Reduce Vulnerability for Recurrent Depression

Clinical Psychological Science October 2, 2015 Thorsten Barnhofer, Julia M. Huntenburg, Michael Lifshitz et al. 16 citations

This review investigates how recent neuroimaging findings on vulnerability for depression and the mechanisms of mindfulness may serve to inform and enhance the understanding that is guiding the use of mindfulness training in the prevention and treatment of recurrent and chronic depression. In particular, we review evidence suggesting that alterations in default-mode-network activity and...

Relapse prevention in major depressive disorder: Mindfulness-based cognitive therapy versus an active control condition.

Journal of Consulting and Clinical Psychology October 2015 Amanda J Shallcross, James J. Gross, Pallavi Visvanathan et al.

We evaluated the comparative effectiveness of mindfulness-based cognitive therapy (MBCT) versus an active control condition (ACC) for depression relapse prevention, depressive symptom reduction, and improvement in life satisfaction. Ninety-two participants in remission from major depressive disorder with residual depressive symptoms were randomized to either an 8-week MBCT or a validated ACC...

Mindfulness-Based Cognitive Therapy for Perinatal Women with Depression or Bipolar Spectrum Disorder.

Cognitive Therapy and Research October 2015 David J. Miklowitz, Randye J Semple, Monika Hauser et al.

The perinatal period is a high-risk time for mood deterioration among women vulnerable to depression. This study examined feasibility, acceptability, and improvement associated with mindfulness-based cognitive therapy (MBCT) in perinatal women with major depressive disorder (MDD) or bipolar spectrum disorder (BSD). Following a diagnostic evaluation, 39 perinatal women with a lifetime history of...

Effect of Ketamine, Thiopental and Ketamine-Thiopental Combination during Electroconvulsive Therapy for Depression.

Turkish journal of anaesthesiology and reanimation October 2015 Özlem Özkan Kuşçu, Feride Karacaer, Ebru Biricik et al.

We aimed to evaluate the effect of anaesthesia with thiopental (4 mg kg(-1)), ketamine (1 mg kg(-1)) and ketamine-thiopental (1 mg kg(-1) and 4 mg kg(-1), respectively) combination during electroconvulsive therapy (ECT) on the Hamilton Depression Rating Scale (HDRS) and Hamilton Anxiety Rating Scale (HAM-A) and haemodynamic variables in patients with resistant major depression. Patients with...

Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression

American Journal of Psychiatry October 1, 2015 D. Jeffrey Newport, Linda L. Carpenter, William M. Mcdonald et al. 594 citations

OBJECTIVE: The authors conducted a systematic review and meta-analysis of ketamine and other N-methyl-d-aspartate (NMDA) receptor antagonists in the treatment of major depression. METHOD: Searches of MEDLINE, PsycINFO, and other databases were conducted for placebo-controlled, double-blind, randomized clinical trials of NMDA antagonists in the treatment of depression. Primary outcomes were...

Ketamine for depression: evidence, challenges and promise

World Psychiatry September 25, 2015 Carlos A. Zarate, Mark J. Niciu 63 citations

Major depressive disorder and bipolar depression are among the most prevalent and disabling mental disorders worldwide. Real-world effectiveness trials in major depressive disorder have underscored that most pharmacological options target monoamines, which are involved in a minority (15-20%) of synaptic contacts in the mammalian brain. Most synapses (∼50%) use the amino acid glutamate as their...

Antidepressant Effect of Combined Ketamine and Electroconvulsive Therapy on Patients With Major Depressive Disorder: A Randomized Trial

Iranian Journal of Psychiatry and Behavioral Sciences September 23, 2015 Narges Shams-Alizadeh, Azad Maroufi, Karim Nasseri et al. 34 citations

BACKGROUND: One of the shortcomings of the available treatments for major depressive disorder (MDD) is the time delay between starting the treatment and achieving an antidepressant response. OBJECTIVES: We aimed to determine the effect of Ketamine as a synergistic antidepressant and anesthetic agent on MDD in electroconvulsive therapy (ECT). PATIENTS AND METHODS: Twenty-two patients with MDD...

The Impact of a Mindfulness Based Program on Perceived Stress, Anxiety, Depression and Sleep of Incarcerated Women.

International Journal of Environmental Research and Public Health September 16, 2015 Ginette G Ferszt, Robin J Miller, Joyce E Hickey et al.

Incarcerated women enter the prison setting with remarkable histories of trauma, mental health and substance abuse issues. Given the stress of incarceration and separation from their children, families, and significant others, it is not surprising that many women experience increased anxiety, depression, and problems with sleep. Due to these negative outcomes, it is imperative to find efficient...

Auditory verbal hallucinations in bipolar disorder (BD) and major depressive disorder (MDD): A systematic review.

Journal of Affective Disorders September 15, 2015 Wei Lin Toh, Neil Thomas, Susan L. Rossell

Auditory verbal hallucinations (AVHs) are not uncommon in bipolar disorder (BD) and major depressive disorder (MDD), but there has been scant research in the area. The current paper aims to draw together and provide a critical overview of existing studies of AVHs in BD and MDD. A systematic review was undertaken using the search terms 'hallucinations' or 'hearing voices' in conjunction with...

The effect of body-mind relaxation meditation induction on major depressive disorder: A resting-state fMRI study.

Journal of Affective Disorders September 1, 2015 Fangfang Chen, Xueyu Lv, Jiliang Fang et al.

Meditation has been increasingly evaluated as an important complementary therapeutic tool for the treatment of depression. The present study employed resting-state functional magnetic resonance imaging (rs-fMRI) to examine the effect of body-mind relaxation meditation induction (BMRMI) on the brain activity of depressed patients and to investigate possible mechanisms of action for this complex...

DOI: 10.1016/j.jad.2015.04.030 (opens in new tab) Full text (opens in new tab) Major depressive disorder Body–mind relaxation meditation Cognitive reappraisal Medial frontal cortex +2